Potential contributors may include baseline reward sensitivity, emotional eating tendency, metabolic status, diabetes status, medication adherence, gastrointestinal tolerability, prior dietary patterns, and broader psychological context, but these variables have not yet been systematically integrated
Disproportionality analysis First, primary analysis was conducted to compare GLP-1RAs with other drugs in the FAERS database
This matters especially because weight loss doesnt always tell the full story: significant weight loss, particularly with GLP-1 medications, can result in muscle loss, with 30 to 40% of the weight lost potentially coming from lean mass
doi: 10.1016/j.physbeh.2022.113967 Summary Keywords glucagon-like peptide-1 receptor agonists, psychiatric adverse events, disproportionality analyses, FAERS database, pharmacovigilance study Citation Chen W, Cai P, Zou W and Fu Z (2024) Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database
The peptide also tolerates lyophilisation and reconstitution without measurable loss of activity, and stable storage at -20C exceeds 24 months in published shelf-life data
For the arms, a surgeon might recommend a brachioplasty, or arm lift, as the initial procedure if severe excess skin already exists
